Clinical Outcomes (12 Weeks, n=90)
▶️ 42% Faster PIH Clearance
vs placebo group (p<0001), measured viaVISIA® melanin index
▶️ Mechanistic Action:
- ↑ 58-fold Bifidobacterium growth → boosts butyrate production,
- Serum butyrate levels correlate with ↓ systemic inflammation (CRP ↓31%),
- Downregulates cutaneous MITF/tyrosinasepathway via IL-10 signaling
▶️ Dual Skin Benefits:
- 89% participants reported reduced redness& sensitivity,
- ↑ Skin luminosity (Δ +187%) and barrier function (TEWL ↓26%)
Formulation Opportunities:
•OralSupplements: 6g/day fiber blend + Lactobacillus probiotics (validated synergy),
•TopicalSerums: Prebiotic-infused actives to support microbiome balance post-acne,
•MedicalAesthetics: Combine with microneedling for enhanced pigment clearance
Blue Eyes Biotech CO, Ltd Delivers Clinically-ValidatedPrebiotic Systems:
✅ Synbiotic Kits: Prebiotic fibers (chicoryroot inulin, acacia FOS) + probiotic strains (sachet/tablet formats),
✅ Topical Actives: Low-MW prebioticcomplexes (05–2% inclusion) for creams/essences,
✅ Clean & Traceable: Non-GMO,allergen-free, ECOCERT®/ISO 22000 certified
Procurement Advantages:
→Clinicalprotocol included: Enables faster product claims substantiation,
→Dual-formatsourcing: Bulk fibers for supplements or ready-to-use cosmetic complexes,
→Full dossiersupport: PIH reduction data, stability testing, safety profiles (HRIPT/COA)
Pioneer the Next Era of Microbiome Skincare:
Download clinical study whitepaper &request sample kits: